SEC Form 4 · accession 0001127430-18-000078
INSMED Inc · INSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melvin Sharoky M.D.
Director
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001104506
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Nov 9, 2018 | P | 10,000 | $16.34 | A | 10,000 | I | Held by family LLC |
| Common StockF3 | Nov 9, 2018 | P | 1,205 | $16.35 | A | 11,205 | I | Held by family LLC |
| Common StockF2,F3 | Nov 12, 2018 | P | 8,795 | $15.5895 | A | 20,000 | I | Held by family LLC |
| Common Stock | holding | — | — | — | 231,794 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $16.31 to $16.40. The number of shares sold at each separate price will be made available to the SEC staff, the issuer or a security holder of the issuer upon request.
- F2The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $15.57 to $15.59. The number of shares sold at each separate price will be made available to the SEC staff, the issuer or a security holder of the issuer upon request.
- F3The reporting person has sole voting control of the LLC, but shares ownership with certain family members.